 Connection
Greggory LaBerge to Humans
This is a "connection" page, showing publications Greggory LaBerge has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.147 |
|
|
|
-
LaBerge G, Duvall E, Grasmick Z, Haedicke K, Galan A, Pawelek J. A melanoma patient with macrophage-cancer cell hybrids in the primary tumor, a lymph node metastasis and a brain metastasis. Cancer Genet. 2021 08; 256-257:162-164.
Score: 0.021
-
LaBerge GS, Duvall E, Grasmick Z, Haedicke K, Galan A, Leverett J, Baswan S, Yim S, Pawelek J. Recent Advances in Studies of Skin Color and Skin Cancer. Yale J Biol Med. 2020 03; 93(1):69-80.
Score: 0.019
-
Laberge GS, Duvall E, Haedicke K, Pawelek J. Leukocyte?Cancer Cell Fusion-Genesis of a Deadly Journey. Cells. 2019 02 18; 8(2).
Score: 0.018
-
Katilius E, Carmel AB, Koss H, O'Connell D, Smith BC, Sanders GM, LaBerge GS. Sperm cell purification from mock forensic swabs using SOMAmer? affinity reagents. Forensic Sci Int Genet. 2018 07; 35:9-13.
Score: 0.017
-
LaBerge GS, Duvall E, Grasmick Z, Haedicke K, Pawelek J. A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis. PLoS One. 2017; 12(2):e0168581.
Score: 0.016
-
Laberge GS, Birlea SA, Fain PR, Spritz RA. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population. Pigment Cell Melanoma Res. 2008 Apr; 21(2):206-8.
Score: 0.008
-
LaBerge GS, Bennett DC, Fain PR, Spritz RA. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol. 2008 Jul; 128(7):1757-62.
Score: 0.008
-
Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA. Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 2005 Aug; 18(4):300-5.
Score: 0.007
-
Danielson PB, Kristinsson R, Shelton RJ, Laberge GS. Separating human DNA mixtures using denaturing high-performance liquid chromatography. Expert Rev Mol Diagn. 2005 Jan; 5(1):53-63.
Score: 0.007
-
Danielson PB, Shelton RJ, LaBerge GS. Clinical applications of denaturing high-performance liquid chromatography-based genotyping. Croat Med J. 2003 Aug; 44(4):447-54.
Score: 0.006
-
LaBerge GS, Shelton RJ, Danielson PB. Forensic utility of mitochondrial DNA analysis based on denaturing high-performance liquid chromatography. Croat Med J. 2003 Jun; 44(3):281-8.
Score: 0.006
-
Kooakachai M, LaBerge G, Santorico SA. A new framework to test parent-child and full sibling relationships with population substructure. Forensic Sci Int. 2019 Dec; 305:110012.
Score: 0.005
-
Lazova R, Laberge GS, Duvall E, Spoelstra N, Klump V, Sznol M, Cooper D, Spritz RA, Chang JT, Pawelek JM. A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer. PLoS One. 2013; 8(6):e66731.
Score: 0.003
-
Birlea SA, Laberge GS, Procopciuc LM, Fain PR, Spritz RA. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Pigment Cell Melanoma Res. 2009 Apr; 22(2):230-4.
Score: 0.002
-
Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007 Mar 22; 356(12):1216-25.
Score: 0.002
-
Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, Bennett DC, Spritz RA. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003 Jun; 72(6):1560-4.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|